Drug intelligence / Profile preview

Ciproflox

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

Ciproflox is a fluoroquinolone antibiotic developed and marketed by Laboratorios Senosiain. It contains the active ingredient ciprofloxacin, which acts by inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV. These enzymes are essential for bacterial DNA replication, transcription, repair, and recombination. Ciproflox is indicated for various bacterial infections, including bone and joint infections, gynecological infections, respiratory infections, middle ear infections, sinusitis, soft tissue infections, urinary tract infections, genital organ infections, typhoid fever, and shigellosis. It is available in oral capsule and intravenous solution formulations.

Brand names
Ciproflox
Other names
ciprofloxacinciprofloxacin hydrochloride monohydrateciprofloxacin lactate
02

Targets

Topo IV (Bacterial Topoisomerase IV)DNA gyrase

Beyond the preview

Go deeper on Ciproflox.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ciproflox.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call